[Treatment of native coarctation in adults]

Youssef Touma1, Anthony N'Guyen, Nadia N'Guyen

  • 1AP-HP, groupe hospitalier Pitié-Salpêtrière, institut de cardiologie, université Pierre-et-Marie-Curie, Paris VI, service de chirurgie thoracique et cardiovasculaire, 47-83, boulevard de l'hôpital, 75651 Paris cedex 13, France.

Presse Medicale (Paris, France : 1983)
|April 23, 2013
PubMed

Insights

Aortic coarctation involves a broader vasculopathy, requiring screening for related heart issues. Lifelong surveillance is crucial after surgical repair or angioplasty due to potential complications like recoarctation.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Pediatric Cardiology

Context:

  • Aortic coarctation is a congenital heart defect often associated with broader arterial disease.
  • Patients require comprehensive evaluation for concurrent cardiac and great vessel anomalies.
  • Understanding the long-term implications of treatment is essential for patient management.

Purpose:

  • To highlight the systemic nature of aortic coarctation beyond the primary defect.
  • To emphasize the necessity of screening for associated cardiovascular conditions.
  • To review current treatment modalities and their potential complications.

Summary:

  • Aortic coarctation reflects a wider vasculopathy affecting the arterial tree proximal to the coarctation.
  • Screening for associated heart disease and supra-aortic vessel anomalies is recommended.
  • Treatment options include surgical repair or balloon angioplasty, with potential complications of recoarctation and aneurysms necessitating lifelong surveillance.
  • Systemic hypertension may persist in adults post-treatment, underscoring the need to address recoarctation and hypoplasia.

Impact:

  • Informs clinical practice regarding comprehensive patient assessment and management strategies for aortic coarctation.
  • Underscores the importance of lifelong surveillance to monitor for treatment complications and persistent hypertension.
  • Contributes to the understanding of vasculopathy associated with aortic coarctation, guiding future research and therapeutic approaches.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...